The protective gene EPHX3, known as epoxide hydrolase 3, whose hypermethylation is responsible for the development of OSCC (Morandi et al., 2017), contributes to predict the survival of HNSCC patients (Bai et al., 2019). This evidence concerns the gene EPHX3 and head and neck squamous cell carcinoma.